Collegium Pharmaceutical COLL Stock
Collegium Pharmaceutical Price Chart
Collegium Pharmaceutical COLL Financial and Trading Overview
| Collegium Pharmaceutical stock price | 36.27 USD |
| Previous Close | 35.23 USD |
| Open | 35.15 USD |
| Bid | 25.15 USD x 200 |
| Ask | 44.88 USD x 200 |
| Day's Range | 34.65 - 35.54 USD |
| 52 Week Range | 29.19 - 50.79 USD |
| Volume | 331.55K USD |
| Avg. Volume | 452.23K USD |
| Market Cap | 1.13B USD |
| Beta (5Y Monthly) | 0.732 |
| PE Ratio (TTM) | 16.902912 |
| EPS (TTM) | 2.06 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 54.33 USD |
COLL Valuation Measures
| Enterprise Value | 1.64B USD |
| Trailing P/E | 16.902912 |
| Forward P/E | 4.574597 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.4181863 |
| Price/Book (mrq) | 3.6116586 |
| Enterprise Value/Revenue | 2.056 |
| Enterprise Value/EBITDA | 3.852 |
Trading Information
Collegium Pharmaceutical Stock Price History
| Beta (5Y Monthly) | 0.732 |
| 52-Week Change | 7.31% |
| S&P500 52-Week Change | 20.84% |
| 52 Week High | 50.79 USD |
| 52 Week Low | 29.19 USD |
| 50-Day Moving Average | 34.65 USD |
| 200-Day Moving Average | 39.21 USD |
COLL Share Statistics
| Avg. Volume (3 month) | 452.23K USD |
| Avg. Daily Volume (10-Days) | 568.93K USD |
| Shares Outstanding | 32.43M |
| Float | 32.05M |
| Short Ratio | 11.92 |
| % Held by Insiders | 1.15% |
| % Held by Institutions | 128.14% |
| Shares Short | 5.47M |
| Short % of Float | 20.15% |
| Short % of Shares Outstanding | 16.85% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 9.41% |
| Operating Margin (ttm) | 15.96% |
| Gross Margin | 89.16% |
| EBITDA Margin | 53.37% |
Management Effectiveness
| Return on Assets (ttm) | 7.59% |
| Return on Equity (ttm) | 27.41% |
Income Statement
| Revenue (ttm) | 796.33M USD |
| Revenue Per Share (ttm) | 25.06 USD |
| Quarterly Revenue Growth (yoy) | 8.90% |
| Gross Profit (ttm) | 710.08M USD |
| EBITDA | 425.05M USD |
| Net Income Avi to Common (ttm) | 74.95M USD |
| Diluted EPS (ttm) | 2.06 |
| Quarterly Earnings Growth (yoy) | 499.80% |
Balance Sheet
| Total Cash (mrq) | 421.75M USD |
| Total Cash Per Share (mrq) | 13 USD |
| Total Debt (mrq) | 929.69M USD |
| Total Debt/Equity (mrq) | 297.58 USD |
| Current Ratio (mrq) | 1.714 |
| Book Value Per Share (mrq) | 9.641 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 331.04M USD |
| Levered Free Cash Flow (ttm) | 332.62M USD |
Profile of Collegium Pharmaceutical
| Country | United States |
| State | MA |
| City | Stoughton |
| Address | 100 Technology Center Drive |
| ZIP | 02072 |
| Phone | 781 713 3699 |
| Website | https://www.collegiumpharma.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 423 |
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Q&A For Collegium Pharmaceutical Stock
What is a current COLL stock price?
Collegium Pharmaceutical COLL stock price today per share is 36.27 USD.
How to purchase Collegium Pharmaceutical stock?
You can buy COLL shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Collegium Pharmaceutical?
The stock symbol or ticker of Collegium Pharmaceutical is COLL.
Which industry does the Collegium Pharmaceutical company belong to?
The Collegium Pharmaceutical industry is Drug Manufacturers - Specialty & Generic.
How many shares does Collegium Pharmaceutical have in circulation?
The max supply of Collegium Pharmaceutical shares is 32.43M.
What is Collegium Pharmaceutical Price to Earnings Ratio (PE Ratio)?
Collegium Pharmaceutical PE Ratio is 17.60436800 now.
What was Collegium Pharmaceutical earnings per share over the trailing 12 months (TTM)?
Collegium Pharmaceutical EPS is 2.06 USD over the trailing 12 months.
Which sector does the Collegium Pharmaceutical company belong to?
The Collegium Pharmaceutical sector is Healthcare.
Collegium Pharmaceutical COLL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26266.39 USD — |
+0.61
|
4.11B USD — | 26041.13 USD — | 26316.81 USD — | — - | 4.11B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12894.4 USD — |
+0.62
|
— — | 12785.35 USD — | 12920.04 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6548.43 USD — |
+0.49
|
— — | 6454.97 USD — | 6553.55 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1250.79 USD — |
+0.77
|
— — | 1233.72 USD — | 1252.43 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
32404.22 USD — |
+0.61
|
— — | 32125.24 USD — | 32465.34 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
|
US Tech Biotechnology Total Retu
XNBI
US
|
7150.53 USD — |
+0.54
|
— — | 7044.78 USD — | 7152.37 USD — | — - | — — |
- {{ link.label }} {{link}}